Search

everythinglearnresearchcommunity

for

Search:↓

Camellia seed cake extract may help hair growth by blocking the hair loss effects of a hormone called DHT.

CSC is linked to mineralocorticoid receptor damage, stress, and steroid use, with treatments including drugs and laser therapies to prevent eye damage.

Finasteride effectively treats central serous chorioretinopathy.

COVID-19 is caused by a virus from bats, and efforts focus on prevention and treatment research.

The InCISE score is a promising tool for assessing wound healing in head and neck surgery but needs more research for broader use.

A CCS patient with severe complications was successfully treated using combined therapies.

Small bowel lesions in Cronkhite-Canada syndrome persist despite steroid treatment.

Regular endoscopic checks are crucial for Cronkhite-Canada syndrome patients to catch potential cancers early.

Traditional Chinese medicine may help relieve symptoms of Cronkhite-Canada syndrome.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.

Cronkhite-Canada syndrome is a rare, non-inherited condition causing various symptoms like polyps, hair loss, and weight loss.

Cronkhite-Canada syndrome may be more treatable and less severe than previously thought.

Albumin and prednisone improved symptoms in a woman with Cronkhite-Canada syndrome, revealing potential genetic causes.

The JCCP's Premises Standards aim to make non-surgical cosmetic treatments safer and higher quality.

Surgical excision is the best treatment for SCC, but intralesional cidofovir might be a viable alternative.

Enteral supplements can improve symptoms of Cronkhite-Canada syndrome.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

Csdc2 helps hair growth in cashmere goats by regulating specific genes.

More research is needed on CCCA in children, especially Black and Asian adolescents.

The study aims to find the best treatment for central serous chorioretinopathy by comparing various options.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

Cronkhite-Canada syndrome is rare, with high mortality and cancer risk, needing more research for treatment guidelines.

Early diagnosis and nutritional support are crucial for managing Cronkhite-Canada Syndrome.

SR-ECDi helps better understand and map the chiroptical properties of solid chiral materials.

A woman with both Cronkhite-Canada syndrome and myelodysplastic syndrome improved significantly with corticosteroid treatment.

Intralesional cidofovir may be a viable alternative treatment for SCC.

The research found that the properties of solid-state Electronic Circular Dichroism (ss-ECD) are influenced by the orientation of local crystals, which could help in examining and mapping chiral materials like pharmaceutical ingredients.

Cronkhite-Canada syndrome can cause multiple gastrointestinal polyps and various physical symptoms.